(Q85855484)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25344905%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

title

Fecal calprotectin and the clinical activity index are both useful to monitor medical treatment in patients with ulcerative colitis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25344905%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25344905%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

author name string

Emanuel Burri

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25344905%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Christoph Beglinger

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25344905%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Frank Serge Lehmann

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25344905%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

publication date

26 October 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25344905%20AND%20SRC:MED&resulttype=core&format=json

Digestive Diseases and Sciences

21 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25344905%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

volume

60

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25344905%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25344905%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

page(s)

485-491

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25344905%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s10620-014-3383-0

21 February 2020

exact match

0 references

cites work

Review article: Crohn's disease: monitoring disease activity

1 reference

12 December 2020

Faecal calprotectin -- a useful tool in the management of inflammatory bowel disease

1 reference

12 December 2020

The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management

1 reference

12 December 2020

Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology

1 reference

12 December 2020

Value of fecal calprotectin in the evaluation of patients with abdominal discomfort: an observational study

1 reference

12 December 2020

Fecal calprotectin more accurately reflects endoscopic activity of ulcerative colitis than the Lichtiger Index, C-reactive protein, platelets, hemoglobin, and blood leukocytes.

1 reference

12 December 2020

Evaluation of disease activity in IBD at the time of diagnosis by the use of clinical, biochemical, and fecal markers

1 reference

12 December 2020

Clinical remission in Crohn's disease--assessment using faecal 111In granulocyte excretion

1 reference

12 December 2020

Phagocyte-specific calcium-binding S100 proteins as clinical laboratory markers of inflammation

1 reference

12 December 2020

Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial

1 reference

12 December 2020

Serial fecal calprotectin changes in children with Crohn's disease on treatment with exclusive enteral nutrition: associations with disease activity, treatment response, and prediction of a clinical relapse

1 reference

12 December 2020

Correlation between faecal excretion of indium-111-labelled granulocytes and calprotectin, a granulocyte marker protein, in patients with inflammatory bowel disease

1 reference

12 December 2020

Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease

1 reference

12 December 2020

Faecal calprotectin in children with clinically quiescent inflammatory bowel disease

1 reference

12 December 2020

Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices

1 reference

12 December 2020

Fast and sharp decrease in calprotectin predicts remission by infliximab in anti-TNF naïve patients with ulcerative colitis.

1 reference

12 December 2020

Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study

1 reference

12 December 2020

Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis

1 reference

12 December 2020

Use of surrogate markers of inflammation and Rome criteria to distinguish organic from nonorganic intestinal disease

1 reference

12 December 2020

Evaluation of inflammatory activity in Crohn's disease and ulcerative colitis

1 reference

12 December 2020

Natural history and complications of IBD.

1 reference

12 December 2020

Fecal calprotectin, lactoferrin, and endoscopic disease activity in monitoring anti-TNF-alpha therapy for Crohn's disease

1 reference

12 December 2020

Fecal calprotectin and lactoferrin for the prediction of inflammatory bowel disease relapse.

1 reference

12 December 2020

Does fecal calprotectin predict relapse in patients with Crohn's disease and ulcerative colitis?

1 reference

12 December 2020

Faecal calprotectin and lactoferrin are reliable surrogate markers of endoscopic response during Crohn's disease treatment

1 reference

12 December 2020

Fecal calprotectin in predicting relapse of inflammatory bowel diseases: a meta-analysis of prospective studies

1 reference

12 December 2020

Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn's disease

1 reference

12 December 2020

Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 2: current management

1 reference

12 December 2020

Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease

1 reference

12 December 2020

Fecal markers of inflammation used as surrogate markers for treatment outcome in relapsing inflammatory bowel disease

1 reference

12 December 2020

Consecutive fecal calprotectin measurements to predict relapse in patients with ulcerative colitis receiving infliximab maintenance therapy.

1 reference

12 December 2020

Endoscopic management of inflammatory bowel disease

1 reference

12 December 2020

Can calprotectin predict relapse risk in inflammatory bowel disease?

1 reference

12 December 2020

Ulcerative colitis: correlation of the Rachmilewitz endoscopic activity index with fecal calprotectin, clinical activity, C-reactive protein, and blood leukocytes

1 reference

12 December 2020